ocrelizumab: what to know about the first agent approved for primary progressive ms
Published 7 years ago • 36K plays • Length 5:47Download video MP4
Download video MP3
Similar videos
-
20:37
ocrelizumab in primary progressive multiple sclerosis (ppms)
-
5:55
ocrelizumab shows first signs of promise for patients with primary progressive multiple sclerosis
-
2:35
ocrelizumab, and treating primary progressive multiple sclerosis
-
16:28
what you need to know about ocrevus
-
1:39
june halper: what ocrelizumab has shown in ppms
-
6:31
ocrelizumab use in treating multiple sclerosis
-
49:12
multiple sclerosis webinar: ocrelizumab q&a with dr. tim vollmer
-
5:54
ensemble study results, ocrelizumab as promising early treatment for ms
-
50:03
multiple sclerosis webinar: ocrelizumab q&a with dr. enrique alvarez
-
3:59
treating forms of ms with ocrelizumab
-
18:29
ocrevus 101: explore an ms treatment option
-
17:49
beyond the basics of ms: lesions and relapses
-
3:44
paulo fontoura, md, phd: ocrelizumab, advanced measures for ppms
-
14:19
ocrevus in primary progressive multiple sclerosis 6.5-year data [orotorio extension study]
-
31:03
multiple sclerosis
-
9:54
progressive ms: where are we and where do we go from here? report from ectrims
-
5:46
ocrelizumab provides potential answer to difficult treatment questions
-
25:18
primary progressive multiple sclerosis (ppms)
-
1:23:00
understanding ms progression: the importance of treatment adherence